Search - tctmd.com

Displaying 121 - 140 of 432

Sort: Relevancy | Date

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

Innovation Gone Wild - Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

Presentation TCT 2019

Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

Presenter: Tamim Nazif

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

Presentation TCT 2019

Experience on the Early Feasibility Study (US Industry’s View)

Presenter: Robert Thatcher

September 26, 2019

Presentation TCT 2019

Experience on the Global Clinical Trial (Japanese Industry’s View)

Presenter: Daiki Yasuhara

September 26, 2019

Presentation TCT 2019

The Basic Regulation Pathway For an Early Feasibility Study in the US

Presenter: Hiren Mistry

September 26, 2019

Presentation TCT 2019

The Basic Regulation Pathway For a Clinical Trial in Japan Compared to US Regulation

Presenter: Mitsuru Yuba

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

News Conference News TCT 2019

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Todd Neale

September 26, 2019

News Conference News TCT 2019

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

L.A. McKeown

September 26, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

Presentation TCT 2019

Polymer-Free DES: Lessons Learned From Recent Trials

Presenter: Michael Maeng

September 26, 2019

Presentation TCT 2019

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

Presenter: Mamas Mamas

September 26, 2019

News Conference News TCT 2019

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

Michael O'Riordan

September 25, 2019

Presentation TCT 2019

TCT 73: The Relative Effects of New Pacemakers versus Left Bundle Branch Block on Clinical and Echocardiographic Outcomes in the PARTNER Trials

Presenter: Tamim Nazif

September 25, 2019

News Industry News

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

September 25, 2019

News Daily News

SCAI Shock Definition Tracks Well With Mortality in Cardiac ICU

Todd Neale

September 24, 2019

News

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Michael O'Riordan

September 24, 2019

Advertisement

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

TCT 2019 Day Two: Transcatheter Valves, New and Old

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Experience on the Early Feasibility Study (US Industry’s View)

Experience on the Global Clinical Trial (Japanese Industry’s View)

The Basic Regulation Pathway For an Early Feasibility Study in the US

The Basic Regulation Pathway For a Clinical Trial in Japan Compared to US Regulation

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Polymer-Free DES: Lessons Learned From Recent Trials

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

TCT 73: The Relative Effects of New Pacemakers versus Left Bundle Branch Block on Clinical and Echocardiographic Outcomes in the PARTNER Trials

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

SCAI Shock Definition Tracks Well With Mortality in Cardiac ICU

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content